BA
QCOR

Boston Advisors’s QUESTCOR PHARMA INC QCOR Stock Holding History

Boston Advisors’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-5,050
Closed -$229K – 616
2013
Q2 		$229K Buy
+5,050
New +$179K 0.01% 479

Other funds holding QCOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Boston Advisors's QCOR Position: Q3 2013 in Review

Boston Advisors sold out of QUESTCOR PHARMA INC (QCOR) in Q3 2013, closing a stake of 5,050 shares — an estimated $229K sold.

Boston Advisors first reported a position in QCOR in Q2 2013 and held it in 1 quarter. The position peaked at $229K in Q2 2013. 284 funds tracked by Wall St. Rank hold QCOR as of Q3 2013.

  • Boston Advisors reported no remaining QUESTCOR PHARMA INC position as of Q3 2013 after selling out during the quarter.
  • Boston Advisors sold 5,050 QUESTCOR PHARMA INC shares in Q3 2013, an estimated $229K.
  • Boston Advisors first reported a position in QUESTCOR PHARMA INC in Q2 2013 and held it in 1 quarter.
  • Boston Advisors's QUESTCOR PHARMA INC position peaked at $229K in Q2 2013.
  • 284 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q3 2013.

Based on Boston Advisors's 13F filing for Q3 2013, filed 23 Oct 2013.